Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Candida Auris and Covid-19: A Health Threatening Combination Publisher



Khojasteh S1, 2, 3 ; Jafarzdeh J4 ; Hosseini SA5 ; Haghani I1, 2 ; Turki H3 ; Gharehbolagh SA6 ; Abastabar M1, 2 ; Mahmoudi S7
Authors

Source: Current Medical Mycology Published:2022


Abstract

Since its first emergence in December 2019, due to its fast distribution throughout the world, SARS-COV-2 become a global concern. With the extremely increased number of hospitalized patients, this situation provided a potential basis for the transmission of nosocomial infections. Candida auris is a multidrug-resistant pathogen with improved transmission dynamics and resistance traits. During the worldwide spread of COVID-19, cases or outbreaks of C. auris colonization or infection have been reported. Resistance to antifungal drugs has been observed in the causative agents of the majority of such cases. The focus in this review is on COVID-19-associated C. auris infections (case studies/outbreaks) and the pandemic's potential effect on antifungal drug resistance. Copyright© 2022, Published by Mazandaran University of Medical Sciences on behalf of Iranian Society of Medical Mycology and Invasive Fungi Research Center.
Other Related Docs
7. Candida Auris: A New Emerging Fungal Monster, Archives of Clinical Infectious Diseases (2019)
8. Candida Auris, an Emerging Fungal Pathogen, Journal of Mazandaran University of Medical Sciences (2019)